Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Video consultations boost survival rates of liver disease patients, study finds

For patients who live in rural areas, driving to see a specialist in a large city or at a university hospital can be challenging, if not impossible.

12 Jun 2018

Research shows that treating cholestasis in father lowers risk of high blood pressure in son

New research led by Professor Catherine Williamson, School of Life Course Sciences, shows that using drugs to treat male mice with cholestasis reduced the likelihood of male offspring developing high blood pressure.

11 Jun 2018

Scientists discover how certain foods can help protect against health issues

The foods we eat play a significant role in our health. Scientists are discovering how eggs, nuts, dairy products, vegetables and even coffee can help protect against health problems.

11 Jun 2018

Naturally occurring antibody can block inflammation in mice, finds study

Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids, molecules on cell surfaces that get modified by inflammation.

7 Jun 2018

Redaction of substance abuse data could result in long-term implications

Due to a change in federal regulation, from 2013-2017, the Centers for Medicare and Medicaid Services redacted any health care encounter that included a diagnosis or procedure code related to substance abuse from the Medicare and Medicaid identifiable files.

5 Jun 2018

Researchers gain new insights into hepatitis B virus

Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

4 Jun 2018

MiNA Therapeutics announces initial results from phase I trial of saRNA candidate in liver cancer patients

MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced preliminary results from its ongoing Phase I study of small activating RNA candidate MTL-CEBPA in advanced liver cancer.

4 Jun 2018

Study proposes a new way to reverse the aging process

A new discovery about the effects of aging in our cells could allow doctors to cure or prevent diabetes, fatty liver disease and other metabolic diseases - and possibly even turn back the clock on aging itself.

29 May 2018

SLU researcher aims to find solutions for diabetes patients at risk of hypoglycemia

A $150,000 grant from The Leona M. and Harry B. Helmsley Charitable Trust will support research at Saint Louis University led by scientist Gina Yosten, Ph.D. Yosten's team is pursuing solutions for people with diabetes who are at risk of life-threatening drops in blood sugar known as hypoglycemia.

25 May 2018

Researchers develop new, rapid blood test to detect liver damage

Chemist Vincent Rotello at the University of Massachusetts Amherst, with colleagues at University College London (UCL), U.K., announce today that they have developed a "quick and robust" blood test that can detect liver damage before symptoms appear, offering what they hope is a significant advance in early detection of liver disease. Details appear in Advanced Materials.

24 May 2018

CU research sheds light on liver disease caused by intravenous nutrition

Research by physician-scientists at the University of Colorado Anschutz Medical Campus offers hope for improved quality of life for people who rely on intravenous nutrition due to intestinal damage.

24 May 2018

Scientists develop lab-based system to study mechanisms of common liver disease

Scientists have developed a lab-based system for studying the most common type of liver disease, paving the way for research into new therapies.

23 May 2018

Specific patterns of fat distribution linked to metabolic disease, shows study

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease and Type 2 Diabetes, according to a new study published in Obesity.

22 May 2018

Study: Medical centers more willing to perform lung transplants for severe alcoholic hepatitis patients

Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease Week® (DDW) 2018.

22 May 2018

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Natural antioxidant bilirubin may provide cardiovascular benefits

Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology study.

18 May 2018

Scientists examine vitamin D levels in children with non-alcoholic fatty liver disease

New research charts vitamin D levels and variations in genes that determine vitamin D status in UK children diagnosed with non-alcoholic fatty liver disease.

15 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

FDA authorizes marketing of Hemospray device for treating GI bleeding

Today, the U.S. Food and Drug Administration permitted marketing of Hemospray, a new device used to help control certain types of bleeding in the gastrointestinal (GI) tract.

8 May 2018

Key metabolites shed by gut bacteria can help protect from inflammation, study finds

Researchers at Tufts University have elucidated a mechanism by which the "good" bacteria that reside in our gastrointestinal tract can help protect us from inflammation, and how their disruption (dysbiosis) can increase the susceptibility of the liver to more harmful forms of disease.

4 May 2018

Liver Disease News and Research

Further Reading

Video consultations boost survival rates of liver disease patients, study finds

Research shows that treating cholestasis in father lowers risk of high blood pressure in son

Scientists discover how certain foods can help protect against health issues

Naturally occurring antibody can block inflammation in mice, finds study

Redaction of substance abuse data could result in long-term implications

Researchers gain new insights into hepatitis B virus

MiNA Therapeutics announces initial results from phase I trial of saRNA candidate in liver cancer patients

Study proposes a new way to reverse the aging process

SLU researcher aims to find solutions for diabetes patients at risk of hypoglycemia

Researchers develop new, rapid blood test to detect liver damage

CU research sheds light on liver disease caused by intravenous nutrition

Scientists develop lab-based system to study mechanisms of common liver disease

Specific patterns of fat distribution linked to metabolic disease, shows study

Study: Medical centers more willing to perform lung transplants for severe alcoholic hepatitis patients

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

Natural antioxidant bilirubin may provide cardiovascular benefits

Scientists examine vitamin D levels in children with non-alcoholic fatty liver disease

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

FDA authorizes marketing of Hemospray device for treating GI bleeding

Key metabolites shed by gut bacteria can help protect from inflammation, study finds

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News